An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
ABSTRACT Influenza, as well as other respiratory viruses, can trigger local and systemic inflammation resulting in an overall “cytokine storm” that produces serious outcomes such as acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). We hypothesized that gene therapy platforms cou...
Saved in:
Main Authors: | Kari Ann Shirey, John Joseph, Lynda Coughlan, Haye Nijhuis, Alan W. Varley, Jorge C. G. Blanco, Stefanie N. Vogel |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2025-02-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03387-24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury
by: Sayantap Datta, et al.
Published: (2025-01-01) -
Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model
by: Sang-A. Oh, et al.
Published: (2025-02-01) -
HMGB1 lactylation drives neutrophil extracellular trap formation in lactate-induced acute kidney injury
by: Li Zhu, et al.
Published: (2025-01-01) -
HMGB1 Box A gene therapy to alleviate bleomycin-induced pulmonary fibrosis in rats
by: Rathasapa Patarat, et al.
Published: (2025-01-01) -
The role of Box A of HMGB1 in producing γH2AX associated DNA breaks in lung cancer
by: Sirapat Settayanon, et al.
Published: (2025-01-01)